跳到正文

Enliven Therapeutics, Inc.(ELVN)内部人交易:高管与董事近期交易

过去 18 个月,共有 12 位内部人为 Enliven Therapeutics, Inc.(ELVN)报告了 175 笔 Form 4 交易(最近一笔 2026-10-05)。

日期内部人职务类型股数市值
2026-10-05Garland J. Scott董事卖出13,000$606,719
2026-10-05Garland J. Scott董事买入13,000$201,110
2026-09-21Collins Helen LouiseCHIEF MEDICAL OFFICER买入5,000$12,400
2026-09-21Hohl BenjaminCHIEF FINANCIAL OFFICER买入3,982$59,133
2026-09-21Collins Helen LouiseCHIEF MEDICAL OFFICER卖出2,916$145,891
2026-09-21Hohl BenjaminCHIEF FINANCIAL OFFICER卖出3,535$176,851
2026-09-21Collins Helen LouiseCHIEF MEDICAL OFFICER卖出1,844$93,507
2026-09-21Hohl BenjaminCHIEF FINANCIAL OFFICER卖出2,194$111,270
2026-09-21Collins Helen LouiseCHIEF MEDICAL OFFICER卖出240$12,356
2026-09-21Hohl BenjaminCHIEF FINANCIAL OFFICER卖出289$14,881
2026-08-19Collins Helen LouiseCHIEF MEDICAL OFFICER卖出3,900$227,650
2026-08-19Hohl BenjaminCHIEF FINANCIAL OFFICER卖出4,630$270,168
2026-08-19Collins Helen LouiseCHIEF MEDICAL OFFICER买入5,000$12,400
2026-08-19Hohl BenjaminCHIEF FINANCIAL OFFICER卖出1,388$82,383
2026-08-19Collins Helen LouiseCHIEF MEDICAL OFFICER卖出1,100$65,281
2026-08-06Derynck Mika K董事买入87,373$216,685
2026-08-06Derynck Mika K董事买入27,567$696,894
2026-08-06Derynck Mika K董事买入23,364$346,955
2026-08-06Derynck Mika K董事买入20,491$460,433
2026-08-06Derynck Mika K董事卖出158,795$9.6M
2026-07-21Collins Helen LouiseCHIEF MEDICAL OFFICER买入5,000$12,400
2026-07-21Hohl BenjaminCHIEF FINANCIAL OFFICER买入1,072$2,659
2026-07-21Collins Helen LouiseCHIEF MEDICAL OFFICER卖出231$11,563
2026-07-21Collins Helen LouiseCHIEF MEDICAL OFFICER卖出459$23,660
2026-07-21Hohl BenjaminCHIEF FINANCIAL OFFICER卖出324$16,191

来源:SEC Form 4 申报文件 · 截至 2026-10-05